The Application of Trimetazidine in Healthy Individuals: A Systematic Review

Author:

Bezuglov EduardORCID,Shoshorina Maria,Zholinsky Andrey,Waśkiewicz Zbigniew,Emanov Anton,Morgans Ryland,Bertholz Vladislav,Zelenskaya Vasilisa,Lazarev Artemii,Sokolskaya Maria,Talibov Oleg

Abstract

AbstractBackgroundCurrently, there is no evidence to support TMZ administration aiming to enhance any parameter of physical performance or post-exercise recovery in healthy individuals of the general population and athletes.ObjectiveConsidering the lack of empirical data, from a scientific and practical perspective it would be interesting to identify research with high methodological quality that examines the effects of trimetazidine (TMZ) on healthy individuals of the general population and athletes of varying age.MethodsData sources included English articles that were searched by keywords in the PubMed and Scopus databases and the Cochrane Library and published prior to November 2022. Thus, a systematic review of the scientific literature was performed utilizing databases with a traditional PRISMA methodology. An initial search by keyword found 2673 publications and the screening process selected 66 articles, of which two articles met the inclusion criteria.ResultsTwo trials examining the effect of TMZ on healthy members of the general population that were published in 2017 and 2019 were analyzed. Athletes were not recruited for this type of research.ConclusionsCurrently there are no data reporting a positive effect of TMZ on physical performance, post-exercise recovery, or other health parameters in members of the general population, while its administration is associated with the development of relatively common adverse effects.

Publisher

Cold Spring Harbor Laboratory

Reference34 articles.

1. Gender Differences in Prevalence and Patterns of Dietary Supplement Use in Elite Athletes;Res Q Exerc Sport,2021

2. Central Beneficial Effects of Trimetazidine on Psychomotor Performance in Normal Healthy Volunteers;Adv Biomed Res,2017

3. The Inclusion in WADA Prohibited List Is Not Always Supported by Scientific Evidence: A Narrative Review;Asian J Sports Med,2021

4. Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France

5. WITHDRAWN: Trimetazidine for stable angina;Cochrane Database Syst Rev,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3